Loss of Colorado Rep. Diana DeGette removes a knowledgeable voice for biopharma in Congress

Colorado Democratic Rep. Diana DeGette was defeated in her primary, ending her service in the U.S. House of Representatives.

DeGette was widely recognized for her deep understanding of biopharma policy, frequently serving as a resource for industry stakeholders even though she was not always an outspoken supporter.

Her departure means the drug industry loses a familiar congressional ally, potentially complicating advocacy efforts as other lawmakers adjust to fill the expertise gap.